Compare $EDIT vs $MYGN | Chartloom

Compare

$EDIT vs $MYGN

Editas Medicine Inc · Myriad Genetics Inc

EDIT

Editas Medicine Inc

MYGN

Myriad Genetics Inc

Compare $EDIT vs $MYGN

Comparing Editas Medicine Inc and Myriad Genetics Inc

EDITEditas Medicine Inc

MYGNMyriad Genetics Inc

EDITEditas Medicine Inc

Market cap

$487M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

27.22x

Rev growth (TTM)

20.8%

YTD performance

41.5%

52W performance

-30.1%

FCF yield

-24.8%

MYGNMyriad Genetics Inc

Market cap

$407M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.50x

Rev growth (TTM)

-3.2%

YTD performance

-29.8%

52W performance

-43.6%

FCF yield

-3.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EDIT

MYGN

Detailed metrics comparison

EDIT

Editas Medicine Inc

MYGN

Myriad Genetics Inc

Market Cap

EDIT$487M

MYGN$407M

Enterprise Value

EDIT$361M

MYGN$413M

Price

EDIT$2.90

MYGN$4.31

P/E Ratio

EDITN/A

MYGNN/A

P/S Ratio

EDIT10.35x

MYGN0.50x

EV/Sales

EDIT7.67x

MYGN0.51x

EV/EBITDA

EDIT0.00x

MYGN49.97x

P/B Ratio

EDIT3.82x

MYGN1.43x

P/FCF Ratio

EDITN/A

MYGNN/A

EV/FCF

EDIT-2.99x

MYGN-29.05x

PEG Ratio

EDITN/A

MYGNN/A

Forward P/E (NTM)

EDITN/A

MYGNN/A

Forward P/S (NTM)

EDIT27.22x

MYGN0.50x

Revenue (TTM)

EDIT$47M

MYGN$807M

Revenue Growth (YoY)

EDIT20.8%

MYGN-3.2%

Forward Rev Growth

EDIT-18.4%

MYGN5.6%

Gross Margin (TTM)

EDIT0.0%

MYGN68.8%

Operating Margin (TTM)

EDIT0.0%

MYGN0.0%

EBITDA Margin (TTM)

EDIT-172.4%

MYGN-5.0%

Net Margin (TTM)

EDIT-157.3%

MYGN-14.0%

FCF Margin (TTM)

EDIT-256.5%

MYGN-1.8%

Net Income (TTM)

EDIT$-74M

MYGN$-113M

FCF (TTM)

EDIT$-121M

MYGN$-14M

EPS (TTM)

EDIT-$0.62

MYGN-$1.19

ROE (TTM)

EDIT-19663.0%

MYGN-3259.0%

ROA (TTM)

EDIT-3817.0%

MYGN-1639.0%

ROIC (TTM)

EDIT-7815.0%

MYGN-2418.0%

Cash

EDIT$182M

MYGN$115M

Debt

EDIT$56M

MYGN$121M

Net Cash/Debt

EDIT$126M

MYGN$-6M

Current Ratio (TTM)

EDIT3.19x

MYGN2.21x

Quick Ratio (TTM)

EDIT3.13x

MYGN1.72x

Debt/Equity (TTM)

EDIT0.53x

MYGN0.40x

Debt/Assets (TTM)

EDIT0.0%

MYGN0.0%

Interest Coverage (TTM)

EDITN/A

MYGNN/A

Net Debt/EBITDA (TTM)

EDIT0.00x

MYGN0.00x

Beta

EDIT2.12

MYGN1.68

52W Performance

EDIT-30.1%

MYGN-43.6%

YTD Performance

EDIT41.5%

MYGN-29.8%

% from 52W High

EDIT-33.0%

MYGN-49.8%

% from 52W Low

EDIT74.7%

MYGN57.3%

Asset Turnover (TTM)

EDIT0.24x

MYGN1.17x

FCF Yield (TTM)

EDIT-24.8%

MYGN-3.5%

Earnings Yield (TTM)

EDIT-15.2%

MYGN-27.7%

Dividend Yield (TTM)

EDITN/A

MYGNN/A

Rule of 40

EDIT-235.6

MYGN-4.9

EV/GP/RG

EDITN/A

MYGN1.67

Ticker research

View EDIT research View MYGN research

Metric	EDIT Editas Medicine Inc	MYGN Myriad Genetics Inc
Market & Valuation
Market Cap	$487M	$407M
Enterprise Value	$361M	$413M
Price	$2.90	$4.31
P/E Ratio	N/A	N/A
P/S Ratio	10.35x	0.50x
EV/Sales	7.67x	0.51x
EV/EBITDA	0.00x	49.97x
P/B Ratio	3.82x	1.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.99x	-29.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.22x	0.50x
Revenue & Growth
Revenue (TTM)	$47M	$807M
Revenue Growth (YoY)	20.8%	-3.2%
Forward Rev Growth	-18.4%	5.6%
Profitability
Gross Margin (TTM)	0.0%	68.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-172.4%	-5.0%
Net Margin (TTM)	-157.3%	-14.0%
FCF Margin (TTM)	-256.5%	-1.8%
Net Income (TTM)	$-74M	$-113M
FCF (TTM)	$-121M	$-14M
EPS (TTM)	-$0.62	-$1.19
ROE (TTM)	-19663.0%	-3259.0%
ROA (TTM)	-3817.0%	-1639.0%
ROIC (TTM)	-7815.0%	-2418.0%
Financial Health
Cash	$182M	$115M
Debt	$56M	$121M
Net Cash/Debt	$126M	$-6M
Current Ratio (TTM)	3.19x	2.21x
Quick Ratio (TTM)	3.13x	1.72x
Debt/Equity (TTM)	0.53x	0.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.12	1.68
52W Performance	-30.1%	-43.6%
YTD Performance	41.5%	-29.8%
% from 52W High	-33.0%	-49.8%
% from 52W Low	74.7%	57.3%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	1.17x
FCF Yield (TTM)	-24.8%	-3.5%
Earnings Yield (TTM)	-15.2%	-27.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-235.6	-4.9
EV/GP/RG	N/A	1.67
Ticker research	View EDIT research	View MYGN research

Valuation

P/S Ratio

MYGN

0.50x

EDIT

10.35x

EV/FCF

MYGN

-29.05x

EDIT

-2.99x

Growth & revenue

Revenue Growth TTM

EDIT

20.8%

MYGN

-3.2%

Forward Revenue Growth

MYGN

5.6%

EDIT

-18.4%

Profitability & performance

Gross Margin

MYGN

68.8%

EDIT

0.0%

ROE

MYGN

-3259.0%

EDIT

-19663.0%

FCF Yield %

MYGN

-3.5%

EDIT

-24.8%

52-Week Performance

EDIT

-30.1%

MYGN

-43.6%

Detailed metrics comparison

EDIT

Editas Medicine Inc

MYGN

Myriad Genetics Inc

Market Cap

EDIT$487M

MYGN$407M

Enterprise Value

EDIT$361M

MYGN$413M

Price

EDIT$2.90

MYGN$4.31

P/E Ratio

EDITN/A

MYGNN/A

P/S Ratio

EDIT10.35x

MYGN0.50x

EV/Sales

EDIT7.67x

MYGN0.51x

EV/EBITDA

EDIT0.00x

MYGN49.97x

P/B Ratio

EDIT3.82x

MYGN1.43x

P/FCF Ratio

EDITN/A

MYGNN/A

EV/FCF

EDIT-2.99x

MYGN-29.05x

PEG Ratio

EDITN/A

MYGNN/A

Forward P/E (NTM)

EDITN/A

MYGNN/A

Forward P/S (NTM)

EDIT27.22x

MYGN0.50x

Revenue (TTM)

EDIT$47M

MYGN$807M

Revenue Growth (YoY)

EDIT20.8%

MYGN-3.2%

Forward Rev Growth

EDIT-18.4%

MYGN5.6%

Gross Margin (TTM)

EDIT0.0%

MYGN68.8%

Operating Margin (TTM)

EDIT0.0%

MYGN0.0%

EBITDA Margin (TTM)

EDIT-172.4%

MYGN-5.0%

Net Margin (TTM)

EDIT-157.3%

MYGN-14.0%

FCF Margin (TTM)

EDIT-256.5%

MYGN-1.8%

Net Income (TTM)

EDIT$-74M

MYGN$-113M

FCF (TTM)

EDIT$-121M

MYGN$-14M

EPS (TTM)

EDIT-$0.62

MYGN-$1.19

ROE (TTM)

EDIT-19663.0%

MYGN-3259.0%

ROA (TTM)

EDIT-3817.0%

MYGN-1639.0%

ROIC (TTM)

EDIT-7815.0%

MYGN-2418.0%

Cash

EDIT$182M

MYGN$115M

Debt

EDIT$56M

MYGN$121M

Net Cash/Debt

EDIT$126M

MYGN$-6M

Current Ratio (TTM)

EDIT3.19x

MYGN2.21x

Quick Ratio (TTM)

EDIT3.13x

MYGN1.72x

Debt/Equity (TTM)

EDIT0.53x

MYGN0.40x

Debt/Assets (TTM)

EDIT0.0%

MYGN0.0%

Interest Coverage (TTM)

EDITN/A

MYGNN/A

Net Debt/EBITDA (TTM)

EDIT0.00x

MYGN0.00x

Beta

EDIT2.12

MYGN1.68

52W Performance

EDIT-30.1%

MYGN-43.6%

YTD Performance

EDIT41.5%

MYGN-29.8%

% from 52W High

EDIT-33.0%

MYGN-49.8%

% from 52W Low

EDIT74.7%

MYGN57.3%

Asset Turnover (TTM)

EDIT0.24x

MYGN1.17x

FCF Yield (TTM)

EDIT-24.8%

MYGN-3.5%

Earnings Yield (TTM)

EDIT-15.2%

MYGN-27.7%

Dividend Yield (TTM)

EDITN/A

MYGNN/A

Rule of 40

EDIT-235.6

MYGN-4.9

EV/GP/RG

EDITN/A

MYGN1.67

Ticker research

View EDIT research View MYGN research

Metric	EDIT Editas Medicine Inc	MYGN Myriad Genetics Inc
Market & Valuation
Market Cap	$487M	$407M
Enterprise Value	$361M	$413M
Price	$2.90	$4.31
P/E Ratio	N/A	N/A
P/S Ratio	10.35x	0.50x
EV/Sales	7.67x	0.51x
EV/EBITDA	0.00x	49.97x
P/B Ratio	3.82x	1.43x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.99x	-29.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	27.22x	0.50x
Revenue & Growth
Revenue (TTM)	$47M	$807M
Revenue Growth (YoY)	20.8%	-3.2%
Forward Rev Growth	-18.4%	5.6%
Profitability
Gross Margin (TTM)	0.0%	68.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-172.4%	-5.0%
Net Margin (TTM)	-157.3%	-14.0%
FCF Margin (TTM)	-256.5%	-1.8%
Net Income (TTM)	$-74M	$-113M
FCF (TTM)	$-121M	$-14M
EPS (TTM)	-$0.62	-$1.19
ROE (TTM)	-19663.0%	-3259.0%
ROA (TTM)	-3817.0%	-1639.0%
ROIC (TTM)	-7815.0%	-2418.0%
Financial Health
Cash	$182M	$115M
Debt	$56M	$121M
Net Cash/Debt	$126M	$-6M
Current Ratio (TTM)	3.19x	2.21x
Quick Ratio (TTM)	3.13x	1.72x
Debt/Equity (TTM)	0.53x	0.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.12	1.68
52W Performance	-30.1%	-43.6%
YTD Performance	41.5%	-29.8%
% from 52W High	-33.0%	-49.8%
% from 52W Low	74.7%	57.3%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	1.17x
FCF Yield (TTM)	-24.8%	-3.5%
Earnings Yield (TTM)	-15.2%	-27.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-235.6	-4.9
EV/GP/RG	N/A	1.67
Ticker research	View EDIT research	View MYGN research